KR970011303B1 - Substituted carboxylic acid derivatives, process for preparing the same and agricultural or horiticultural fungicides containing the same - Google Patents
Substituted carboxylic acid derivatives, process for preparing the same and agricultural or horiticultural fungicides containing the same Download PDFInfo
- Publication number
- KR970011303B1 KR970011303B1 KR1019880014526A KR880014526A KR970011303B1 KR 970011303 B1 KR970011303 B1 KR 970011303B1 KR 1019880014526 A KR1019880014526 A KR 1019880014526A KR 880014526 A KR880014526 A KR 880014526A KR 970011303 B1 KR970011303 B1 KR 970011303B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- group
- formula
- carboxylic acid
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 0 CC1(*)O*(*)c2c1cccc2C Chemical compound CC1(*)O*(*)c2c1cccc2C 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
- A01N43/12—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings condensed with a carbocyclic ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
- A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
요약없음No summary
Description
본 발명은 치환 카르복실산 유도체, 그의 제조방법 및 그를 활성성분으로 함유하는 농업용 또는 원예용 살진균제에 관한 것이다.The present invention relates to a substituted carboxylic acid derivative, a method for preparing the same, and an agricultural or horticultural fungicide containing the same as an active ingredient.
몇몇 카르복실산 유도체의 살균 활성은 예를 들면, 일본국 특허공개 제52-87168, 56-96069호 및 제60-34949호, 미합중국 특허 제4134967호, 지.에이.화이트(G.A.Whites)의 문헌[Pesticide Biochemistry and Physiology 14,26(1960)], 제이.엘.휴파쯔(J.L.Huppatz)의 문헌 [Aust. J. Chem. 36, 135(1983)], 비.잰크(B. Janks)의 문헌[Pestic. Sci., 2, 43, 1971, DEOS 2611601, Chem. Abst.70, 8779j(S. African 67 06, 681 Uniroyal Inc.)], 지. 에이. 화이트 공저(G.A. White et al.)의 문헌 [Pesticide Biochemistry and Physiology 5, 380-395, 1975] 및 엠.셀공저(M. Shell et al.)의 문헌[Phyto-pathology 60, 1164-1169, 1970]에 보고되어 있다. 그러나, 공지의 화합물은 활성에 있어 만족스럽지 않아 높은 살균 활성을 갖는 화학약품이 요구되어 왔다.The bactericidal activity of some carboxylic acid derivatives is described, for example, in Japanese Patent Laid-Open Nos. 52-87168, 56-96069 and 60-34949, US Pat. No. 4134967, GAWhites. Pesticide Biochemistry and Physiology 14,26 (1960), JL Huppatz, Aust. J. Chem. 36, 135 (1983), B. Janks, Pestic. Sci., 2, 43, 1971, DEOS 2611601, Chem. Abst. 70, 8779j (S. African 67 06, 681 Uniroyal Inc.), g. a. GA White et al., Pesticide Biochemistry and Physiology 5, 380-395, 1975, and M. Shell et al., Phyto-pathology 60, 1164-1169, 1970. ]. However, known compounds are not satisfactory in activity, and chemicals having high bactericidal activity have been required.
높은 살균 활성을 갖는 화합물에 관해 심도 있는 연구를 한 결과, 본 발명자들은 하기 식(I)의 치환 카르복실산 유도체(이하 본 발명의 화합물이라 함)를 발견하였다.As a result of an in-depth study on compounds having high bactericidal activity, the inventors found a substituted carboxylic acid derivative of the formula (I) below (hereinafter referred to as the compound of the present invention).
식중, R1은 메틸 또는 에틸기를 나타내고 ;In the formula, R 1 represents a methyl or ethyl group;
A는또는R6을 나타내고 ; R2는 메틸, 에틸 또는 트리플루오로메틸기를 나타내고 ; R3은 메틸기 또는 할로겐 또는 수소원자를 나타내고 ; R4는 불소 또는 수소원자를 나타내고 ; R5는 메틸, 니트로 또는 트리플루오로메틸기 또는 할로겐원자를 나타내고 ; Z는 =CH…기 또는 N원자를 나타내고 ; R6는 메틸, 에틸, 또는 트리플루오토메틸기를 나타내고 ; R7은 아미노, 메틸기 또는 염소원자를 나타낸다.A is or R 6 is represented; R 2 represents a methyl, ethyl or trifluoromethyl group; R 3 represents a methyl group or a halogen or a hydrogen atom; R 4 represents fluorine or a hydrogen atom; R 5 represents methyl, nitro or trifluoromethyl group or halogen atom; Z is = CH... Group or N atom; R 6 represents a methyl, ethyl or trifluorotomethyl group; R 7 represents an amino, methyl group or chlorine atom.
본 발명에 따라, 본 발명의 화합물의 제조방법 및 본 발명의 화합물을 활성 성분으로 함유하는 농업용 또는 원예용 살진균제를 또한 제공한다.According to the invention, there is also provided a method for preparing a compound of the invention and an agricultural or horticultural fungicide containing the compound of the invention as an active ingredient.
본 발명의 화합물은 각종 식물 세균, 특히 바시디오미세트류(Basidiomycetes)에 속하는 세균에 의해 유발되는 식물질병을 방지하고, 치료하고 체계적으로 퇴치하는 효과를 갖고 환경에 역영향을 거의 주지 않는다.The compounds of the present invention have the effect of preventing, treating and systematically combating plant diseases caused by various plant bacteria, in particular, bacteria belonging to Basidiomycetes, and hardly adversely affect the environment.
다음은 본 발명의 화합물이 우수한 퇴치 효과를 갖는 식물질병이다 : 벼에 있어 리족토니아 솔라니(Rhizoctonia solani)및 리족토니아오리자에(Rhizoctonia oryzae), 알.솔라니(R.solani)III B ; 밀 및 보리에 있어 푸치니아 스트리이 포르미스(Puccinia striiformis), 피. 그라미니스(P. graminis), 피. 레콘디타(P. recondita), 피.호르데이(P.hordei), 티플라 인카르나타(Typhula incarnata), 티. 이스히카리엔시스(T. ishikariensis), 유스틸라고 트리티치(Ustilago tritici), 및 유.누다(U. nuda) ; 각종작물에 있어 리족포니아 솔라니(Rhizoctonia solani) 및 코르티슘 롤프시이(Corticium rolfsii) ; 토마토 및 비트에 있어 리족토니아 솔라니(Rhizoctonia solani) ; 배에 있어 김노스포랑금 하라에아늄(Cymnosporangium haraeanum) ; 사과에 있어 벤투리아 아니에쿠알리스(Venturia inaequalis) ; 목초지 및 잔디에 있어 리족토니아 솔라니(Rhizoctonia solani), 코르티슘 롤프시이(Corticium rolfsii), 유로미세스 트리폴리이(Uromyces trifolii) 및 티풀라 인카르나타(Typhula incarnata), 티. 이시카리엔시스(T. ishikariensis)살균 활성면에서 본 발명의 화합물중 바람직한 것은 하기식 (I')의 치환 카르복실산 유도체이고,The following are plant diseases in which the compounds of the present invention have an excellent eradication effect: Rhizoctonia solani and Rhizoctonia oryzae, R. solani III B in rice; Puccinia striiformis, p. In wheat and barley. P. graminis, p. P. recondita, P.hordei, Typhula incarnata, T. T. ishikariensis, Ustilago tritici, and U. nuda; Rhizoctonia solani and Corticium rolfsii in various crops; Rhizoctonia solani on tomatoes and beet; Cymnosporangium haraeanum on the ship; Venturia inaequalis in apples; Rhizoctonia solani, Corticium rolfsii, Uromyces trifolii and Typhula incarnata, T. in pasture and grass. Preferred among the compounds of the present invention in terms of T. ishikariensis bactericidal activity are substituted carboxylic acid derivatives of the following formula (I '),
[식중, R1,R2및R3는 상기 정의한 바와 동일하다]더욱 바람직한 것은 하기식의 것이고,[Wherein, R 1 , R 2 and R 3 are the same as defined above] More preferred are those of the following formula,
[식중, R8은 메틸 또는 트리플루오로메틸기를 나타내고, R9는 할로겐원자를 나타낸다][Wherein R 8 represents methyl or trifluoromethyl group and R 9 represents halogen atom]
가장 바람직한 것은Most desirable
이다.to be.
본 발명의 화합물은 내재하는 부제 탄소원자에 기인한 그의 광학 활성이성체를 포함한다. 이성체중 하나는 하기식(II)의 치환 카르복실산 유도체이다.Compounds of the present invention include their optically active isomers due to inherent subtitle carbon atoms. One of the isomers is a substituted carboxylic acid derivative of formula (II) below.
[식중, R1,R2및 R3은 상기 정의한 바와 동일하다][Wherein R 1 , R 2 and R 3 are the same as defined above]
본 발명의 화합물의 제조법을 하기에 자세히 기술한다.The preparation of the compounds of the invention is described in detail below.
[방법(A)][Method (A)]
본 발명의 화합물중 하기식(I)의 치환 카르복실산유도체는 하기식(III)의 치환 카르복실산 또는 그의 반응성 유도체를 하기식(IV)의 치환 4-아미노-2-옥사인단과 반응시켜 제조된다.Among the compounds of the present invention, the substituted carboxylic acid derivative of the following formula (I) reacts the substituted carboxylic acid of the following formula (III) or a reactive derivative thereof with the substituted 4-amino-2-oxane group of the following formula (IV) Are manufactured.
A-COOH…(III)A-COOH... (III)
[식중, A 및 R1은 상기 정의한 바와 동일하다]Wherein A and R 1 are the same as defined above.
반응은 통상 용매존재하에서 수행하나 항상 용매가 필요한 것은 아니다. 용매는 예를 들면 벤젠, 톨루엔및 크실렌과 같은 탄화수소, 클로로벤젠, 메틸렌클로라이드, 클로로포름 및 카아본 테트라클로라이드와 같은 할로겐화 탄화수소, 디이소프로필에테르, 테트라히드로푸란 및 디옥산과 같은 에테르, 아세톤 및 메틸에틸케톤과 같은 케톤, 에틸아세테이트와 같은 에스테르, 아세토니트릴과 같은 니트릴, 디메틸술폭시드, 디메틸포름아미드, 물 등이고, 바람직하게는 테트라히드로푸란이다.The reaction is usually carried out in the presence of a solvent but does not always require a solvent. The solvent is, for example, hydrocarbons such as benzene, toluene and xylene, halogenated hydrocarbons such as chlorobenzene, methylene chloride, chloroform and carbon tetrachloride, ethers such as diisopropylether, tetrahydrofuran and dioxane, acetone and methylethyl Ketones such as ketones, esters such as ethyl acetate, nitriles such as acetonitrile, dimethyl sulfoxide, dimethylformamide, water and the like, preferably tetrahydrofuran.
상기 반응에서 사용된 시약의 양은 식(IV)로 표시되는 치환 4-아미노-2-옥사인단 당량당 식(III)으로 표시되는 치환 카르복실산 또는 그의 반응성 유도체 0.4~1.5당량, 바람직하게는 0.5~1.1당량이다.The amount of the reagent used in the reaction is 0.4-1.5 equivalents, preferably 0.5-substituted carboxylic acids or reactive derivatives thereof represented by formula (III) per substituted 4-amino-2-oxane dan equivalents represented by formula (IV). It is ~ 1.1 equivalency.
반응은 용매의 응결점 내지 비점, 바람직하게는 0℃내지 용매의 비점의 임의적인 온도에서 수행된다.The reaction is carried out at an optional temperature from the freezing point of the solvent to the boiling point, preferably from 0 ° C. to the boiling point of the solvent.
식(III)으로 표시되는 치환 카르복실산 또는 그의 반응성 유도체에는 상응하는 카르복실산, 산무수물, 산염화물, 산부론화물, 카르복실산 에스테르 등이 있다.Substituted carboxylic acids or reactive derivatives thereof represented by formula (III) include the corresponding carboxylic acids, acid anhydrides, acid chlorides, acidbutronides, carboxylic acid esters and the like.
반응은 식(III)으로 표시되는 치환 카르복실산 또는 그의 반응성 유도체에 따라 반응 조제의 존재하에서 수행될 수 있다. 반응 조제에는 예를 들면 카르복실산이 사용될때에는 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드 메티오디드 및 디시클로헥실 카르보디이미드이고, 카르복실산 에스테르가 사용될때에는 수소화나트륨, 소듐메틸레이트, 소듐에틸레이트 등이고, 산할라이드 또는 산무수물을 사용할때에는 수산화나트륨, 수산화칼륨, 트리에틸아민, N-메틸모르폴린, 피리딘등이다. 반응 조제는 통상 촉매량 내지 2당량, 바람직하게는 0.95~1.1 당량의 양으로 사용된다.The reaction can be carried out in the presence of a reaction aid depending on the substituted carboxylic acid or reactive derivative thereof represented by formula (III). Reaction aids are, for example, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide methoxide and dicyclohexyl carbodiimide when carboxylic acid is used, sodium hydride, sodium methyl when carboxylic acid ester is used. It is the rate, sodium ethylate, etc., and when using an acid halide or an acid anhydride, it is sodium hydroxide, potassium hydroxide, triethylamine, N-methylmorpholine, pyridine, etc. The reaction aid is usually used in an amount of catalyst to 2 equivalents, preferably 0.95 to 1.1 equivalents.
반응이 완결된 후, 반응 조제 또는 그의 반응 생성물을 여과하여 제거하고, 물로 세척한다. 용매를 증류하여 제거하여 목적하는 식(I)의 치환 카르복실산 유도체를 수득한다. 필요하면, 생성물을 또한 크로마토그래피, 재결정 등을 하여 정제한다.After the reaction is completed, the reaction aid or its reaction product is filtered off and washed with water. The solvent is distilled off to give the desired substituted carboxylic acid derivative of formula (I). If necessary, the product is further purified by chromatography, recrystallization or the like.
[방법(B)][Method (B)]
본 발명의 화합물중, 식(II)의 치환카르복실산 유도체는 하기식(V)의 치환카르복실산 또는 그의 반응성 유도체를 하기식(VI)의 치환 4-아미노-2-옥사인단과 반응시켜 수득된다.Among the compounds of the present invention, the substituted carboxylic acid derivative of formula (II) is reacted with a substituted 4-amino-2-oxane group of the following formula (VI) Obtained.
[식중, R1,R2및 R3는 상기 정의한 바와 동일하다][Wherein R 1 , R 2 and R 3 are the same as defined above]
반응을 통상 용매의 존재하에 수행하나 용매는 항상 필요하지는 않다. 용매의 예로는 벤젠, 톨루엔및 크실렌 같은 탄화수소, 클로로벤젠, 메틸렌클로라이드, 클로로포름 및 카아본 테트라클로라이드 등과 같은 할로겐과 탄화수소, 디이소프로필에테르, 테트라히드로푸란 및 디옥산과 같은 에테르, 아세톤 및 메틸에틸케톤과 같은 케톤, 에틸아세테이트같은 에스테르, 아세토니트릴과 같은 니트릴, 디메틸술폭시드, 디메틸포름아미드 및 물이 있고, 바람직하게는 테트라히드로푸란이다.The reaction is usually carried out in the presence of a solvent but a solvent is not always necessary. Examples of the solvent include hydrocarbons such as benzene, toluene and xylene, halogens and hydrocarbons such as chlorobenzene, methylene chloride, chloroform and carbon tetrachloride, ethers such as diisopropylether, tetrahydrofuran and dioxane, acetone and methyl ethyl ketone Ketones, such as ethyl acetate, nitriles such as acetonitrile, dimethyl sulfoxide, dimethylformamide and water, preferably tetrahydrofuran.
시약의 양은 식(vI)로 표시되는 치환 4-아미노-2-옥사인단 당량식 식(V)로 표시되는 치환 카르복실산 또는 그의 반응성 유도체 0.4~1.5 당량, 바람직하게는 0.5~1.1 당량이다.The amount of the reagent is 0.4 to 1.5 equivalents, preferably 0.5 to 1.1 equivalents, of the substituted carboxylic acid represented by the formula (VI) or the reactive derivative thereof represented by the formula (V).
반응은 용매의 응결성 내지 비점, 바람직하게는 0℃내지 용매의 비점의 온도에서 수행된다.The reaction is carried out at a temperature from the coagulation to the boiling point of the solvent, preferably from 0 ° C. to the boiling point of the solvent.
식(V)의 치환 카르복실산 또는 그의 반응성 유도체는 상응하는 카르복실산, 산무수물, 산염화물, 산브롬화물 및 카르복실산 에스테스이다.Substituted carboxylic acids or reactive derivatives thereof of formula (V) are the corresponding carboxylic acids, acid anhydrides, acid chlorides, acid bromide and carboxylic acid esters.
반응은 식(V)의 치환 카르복실산 또는 그의 반응성 유도체에 따라 반응 조제 존재하에서 수행될 수 있다. 반응 조제로는 예를 들면 카르복실산이 사용되었을때에는 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드 메리오디드 및 디시클로헥실 카르보디이미드익고 ; 카르복실산 에스테르가 사용되었을때에는 수소화나트륨, 소듐메틸레이트 및 소듐에틸레이트이고 ; 산할라이드 또는 산무수물이 사용되었을때에는 수산화나트륨, 수산화칼륨, 트리에틸아민, N-메틸모르폴린 및 피리딘이다. 반응 조제는 촉메량 내지 2당량, 바람직하게는 0.95~1.1 당량의 양으로 통상 사용된다.The reaction can be carried out in the presence of a reaction aid depending on the substituted carboxylic acid of formula (V) or a reactive derivative thereof. As a reaction adjuvant, for example, when carboxylic acid is used, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide merodide and dicyclohexyl carbodiimide are used; When carboxylic acid esters are used, they are sodium hydride, sodium methylate and sodium ethylate; When acid halides or acid anhydrides are used they are sodium hydroxide, potassium hydroxide, triethylamine, N-methylmorpholine and pyridine. The reaction aid is usually used in an amount of from 2 to 2 equivalents, preferably 0.95 to 1.1 equivalents.
반응이 완결된 후, 반응 조제 또는 그의 반응 생성물을 여과하여 제거하고, 물로 세척한다. 용매를 증류하여 제거하여 목적하는 식(II)의 치환카르복실산 유도체를 수득한다. 필요하면, 생성물을 또한 크로마토그래피, 재결정 등을 하여 정제한다.After the reaction is completed, the reaction aid or its reaction product is filtered off and washed with water. The solvent is distilled off to give the desired substituted carboxylic acid derivative of formula (II). If necessary, the product is further purified by chromatography, recrystallization or the like.
[방법(C)][Method (C)]
본 발명의 화합물중 하기식(VII)의 치환 카르복실산 유도체는 하기식(VIII)의 치환 4-아미노-2-옥사인단 유도체를 하기식(IX)의 티오아미드 유도체와 반응시켜 제조된다.Substituted carboxylic acid derivatives of the following formula (VII) among the compounds of the present invention are prepared by reacting substituted 4-amino-2-oxanedan derivatives of the following formula (VIII) with thioamide derivatives of the following formula (IX).
[식중, R1및 R6는 상기 정의한 바와 동일하고, R10은 아미노 또는 메틸기를 나타낸다][Wherein, R 1 and R 6 are the same as defined above and R 10 represents an amino or methyl group]
반응은 통상 용매존재하에서 수행되나 용매는 항상 필요한 것은 아니다. 용매의 예로는 벤젠, 톨루엔 및 크실렌과 같은 탄화수소, 클로로벤젠과 같은 할로겐화 탄화수소, 디이소프로필에테르, 테트라히드로푸란 및 디옥산과 같은 에테르, 에틸 아세테이트와 같은 에스테르, 메탄올 및 에탄올과 같은 알코올, 디메틸술폭시드, 디메틸포름아미드 및 물이다.The reaction is usually carried out in the presence of a solvent, but a solvent is not always necessary. Examples of solvents include hydrocarbons such as benzene, toluene and xylene, halogenated hydrocarbons such as chlorobenzene, ethers such as diisopropylether, tetrahydrofuran and dioxane, esters such as ethyl acetate, alcohols such as methanol and ethanol, dimethyl sulfoxide Seeds, dimethylformamide and water.
시약의 양은 한정되지는 않으나 통상 식(VIII)의 치환 4-아미노-2-옥사인단 유도체 당량당 식(IX)의 티오아미드 유도체 0.5~10당량, 바람직하게는 1~3당량이다.The amount of the reagent is not limited, but is usually 0.5 to 10 equivalents, preferably 1 to 3 equivalents, of the thioamide derivative of the formula (IX) per equivalent of the substituted 4-amino-2-oxanedan derivative of the formula (VIII).
반응은 용매의 응결점 내지 비점, 바람직하게는 0℃내지 용매의 미점의 온도에서 수행된다.The reaction is carried out at a temperature from the condensation point to the boiling point of the solvent, preferably from 0 ° C. to the dew point of the solvent.
반응은 반응 조제로서 염기의 존재하에서 수행될 수 있다. 염기로는 예를 들면 암모니아수, 트리에틸아민 및 N-메틸모르폴틴과 같은 아민 및 탄산칼륨 및 탄산나트륨과 같은 무기염기이다.The reaction can be carried out in the presence of a base as a reaction aid. Bases are, for example, aqueous ammonia, amines such as triethylamine and N-methylmorpholin, and inorganic bases such as potassium carbonate and sodium carbonate.
반응이 완결된 후, 반응 조제 또는 그의 반응 생성물을 여과하여 제거하고, 물로 세척한 후 목적하는 식(VII)의 치환카르복실산 유도체가 수득될때까지 여액을 증류하여 용매를 제거한다. 필요하면, 생성물을 예를 들면 크로마토그래피하여 정제할 수 있다.After the reaction is completed, the reaction aid or its reaction product is filtered off, washed with water and the filtrate is distilled off to remove the solvent until the desired carboxylic acid derivative of formula (VII) is obtained. If necessary, the product can be purified, for example by chromatography.
[방법 (D)][Method (D)]
본 발명의 화합물중, 식(II)의 치환 카르복실산 유도체는 식(I')의 치환 카르복실산 유도체를 광학적 활성컬럼, 예를 들면 "수미팩 오에이"R4100("Sumipack OA"R4100)(Sumike Chemical Analysis Service Ltd.)에 분리될때까지 이행시켜 수득된다.Substituted carboxylic acid derivatives of the formula (II) of the compounds of the invention include formula (I ') a substituted carboxylic acid derivative, for the optically active column, for example, in "Sumi pack Oei era" R 4100 ( "Sumipack OA" R 4100 Obtained by separation into Sumike Chemical Analysis Service Ltd.
본 발명의 화합물 제조용 시작물질의 하나인 식(IV)로 표시되는 치환 4-아미노-2-옥사인단은 예를 들면 문헌 [예 ; Jean Vene and Jean Tirouflet Compt rend 231, 911-12(1950)]에 기제된 4-아세트 아미노프탈리드로 부터 제조된다.Substituted 4-amino-2-oxane groups represented by formula (IV), which is one of the starting materials for preparing a compound of the present invention, are described, for example, in literature; Jean Vene and Jean Tirouflet Compt rend 231, 911-12 (1950).
[식중, R1은 상기 정의한 바와 동일하다.][Wherein, R 1 is the same as defined above.]
즉 4-아세트아미노프탈리드를 디에틸에테르 및 테트라히 드로푸란과 같은 에테르용메에서 -10℃내지 실온의 온도에서 메틸마그네슘 요오다이드와 같은 메틸그리냐드 시약(4~12당량)과 디올(a)가 수득될때까지 반응시킨다. 디올(a)를 더욱산 및 테트라히드로푸란과 같은 에테르 용매 또는 클로로포름 및 디클로로에탄과 같은 할로겐화 탄화수소내에서 환류하에 활성화된 이산화망간(5~20당량)과 반응시켜 락톤(b)를 수득한다. 그런후, 락톤(b)를 디에틸에테르 및 테트라히드로푸란같은 에테르용매내에서 -30℃내지 실온에서 메틸리튬 또는 에틸티튬(24당량)과 아세탈(c)가 수득될때까지 반으시킨다.That is, 4-acetaminophthalide may be reacted with a methylgrignard reagent (4-12 equivalents) such as methylmagnesium iodide at a temperature of -10 ° C to room temperature in an ether solvent such as diethyl ether and tetrahydrofuran. React until a) is obtained. Diol (a) is reacted with activated manganese dioxide (5-20 equivalents) under reflux in an ether solvent such as further acid and tetrahydrofuran or a halogenated hydrocarbon such as chloroform and dichloroethane to give lactone (b). Lactone (b) is then halved in an ether solvent such as diethyl ether and tetrahydrofuran at -30 ° C. to room temperature until methyllithium or ethyltitanium (24 equivalents) and acetal (c) are obtained.
아세탈(c)를 메탄올 및 에탄올과 같은 알코올 용매에서 실온에서 팔라튬 카아본 및 농염산촉매량존재하에서 아닐리드(d)가 수득될때까지 수소화 반응시킨다. 그런후, 아닐리드(d)를 환류하 에틸렌글리콜 및 물용매내에서 치환 4-아미노-2-옥사인단(IV)가 수득될때까지 수산화나트륨 및 수산화칼슘과 같은 알칼리금속 수산화물(5~20당량)과 반응시킨다.The acetal (c) is hydrogenated in alcohol solvents such as methanol and ethanol at room temperature until an anilide (d) is obtained in the presence of a catalyst of palladium carbon and concentrated hydrochloric acid. Subsequently, the anhydride (d) is reacted with alkali metal hydroxides (5-20 equivalents) such as sodium hydroxide and calcium hydroxide until a substituted 4-amino-2-oxane group (IV) is obtained in ethylene glycol and water solvent under reflux. Let's do it.
식(IV)로 표시되는 치환 4-아미노-2-옥사인단은 예를 들면 치환 4-아미노-2-옥사인단(IV)를 (I)광학 활성 카르복실산 또는 (2)광학 활성 컬럼으로 광분해하여 수득될 수 있다.Substituted 4-amino-2-oxane groups represented by formula (IV) can be used, for example, to photodegrade substituted 4-amino-2-oxane groups (IV) into (I) optically active carboxylic acids or (2) optically active columns. Can be obtained.
본 발명의 화합물을 살균제의 활성성분으로 사용할때, 다른 성분을 가하지 않고 사용할 수 있지만 통상 제제하기 위해 고체 또는 액체 담체, 표면활성제 및 다른 보조제와 혼합하여 유화농축액, 습식분말, 현탁제제, 과립제, 분진, 액체등으로 제제된다.When the compound of the present invention is used as an active ingredient of a bactericide, it can be used without adding other ingredients, but is usually mixed with a solid or liquid carrier, a surface active agent, and other auxiliaries to prepare an emulsion, a wet powder, a suspension, a granule, and a dust It is formulated with liquid.
이 제제내의 활성 성분으로 본 발명의 화합물의 함유량은 0.1내지 99.9중량%, 바람직하게는 0.2내지 80중량%이다.The content of the compound of the present invention as the active ingredient in this formulation is 0.1 to 99.9% by weight, preferably 0.2 to 80% by weight.
고체담체에는 예를 들면, 카을린 클레이, 에터필자이트클레이, 벤토나이트, 애시드 클레이, 피로필라이프, 활석, 규조토, 칼시트, 코온스타아치분말, 호도껍질분말 우레아, 황상암모늄, 합성 수화이산화규소 등의 미세분말 또는 과립이다. 액체 담체로는 예를 들면 크실렌, 메틸나프탈렌 등과 같은 방향족 탄화수소, 이소프로판올, 에틸렌글리콜, 셀로솔브 등과 같은 알코올, 아세톤, 시클로헥사는, 이소포론 등과 같은 케톤, 대두유, 면실유 등과 같은 야채유, 디메틸슬폭시드, 아세토니트릴, 물 등이 있다.Solid carriers include, for example, clay clay, ether filite clay, bentonite, acid clay, pyrophylllifera, talc, diatomaceous earth, calcitic sheet, coon starch powder, rhodium shell powder urea, sulfuric ammonium, synthetic hydrous silicon dioxide, and the like. Fine powder or granules. Examples of the liquid carrier include aromatic hydrocarbons such as xylene and methylnaphthalene, alcohols such as isopropanol, ethylene glycol and cellosolve, acetone and cyclohexa, ketones such as isophorone, vegetable oils such as soybean oil and cottonseed oil, dimethylsulfoxide and the like. , Acetonitrile, water and the like.
유화, 분산, 습식 등에 사용되는 표면활성제에는 예를 들면 알킬술페이트, 알킬(아릴)술포네이트, 디알킬-술포숙시네이트의 염, 폴리옥시에틸렌 알킬아릴에테르 인산에스테르, 나프탈렌술폰산/포르말린 농축물 등의 염과 같은 음이온계표면활성제 및 폴리옥시에틸렌 알킬에테르, 폴리옥시에틸렌폴리옥시프로필렌 블록공중합체, 소트비탄 지방산 에스테르, 폴리옥시에틸렌소르비탄지방산 에스테르 등과 같은 비이온계표면활성제이다. 제제용 부가제로는 예를 들면 리그노슬포네이트, 알기네이트, 폴리비닐 알코올, 아리비아검, CMC(카르복시메틸 셀룰로오스), PAP(산성 이소프로필 포스페이트)등이다.Surfactants used in emulsification, dispersion, wetness, etc. include, for example, alkyl sulfates, alkyl (aryl) sulfonates, salts of dialkyl-sulfosuccinates, polyoxyethylene alkylaryl ether phosphate esters, naphthalenesulfonic acid / formalin concentrates. Anionic surfactants such as salts, and nonionic surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene polyoxypropylene block copolymers, sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters and the like. Examples of the additive for the preparation include lignosulfonates, alginates, polyvinyl alcohols, arivia gums, CMC (carboxymethyl cellulose), PAP (acidic isopropyl phosphate), and the like.
이 제제는 그 자체로 또는 예를 들면 물로 희석되어 토양또는 식물에 직접 투여된다. 더욱 상세하게는 이들을 각종형태, 예를 들면 식물상에 분사 또는 분진, 토양 표면상에 분사, 분진 또는 과립-스프린클링 또는 필요하면 부차적인 토양함입으로 투여된다. 또한, 이 제제를 종자처리제로 사용할 경우, 종자를 이 제제로 덮거나 이 제젱 담근다. 제제는 다른 살균제, 살해충제, 살진드기제, 살식물선충제, 제초제, 식물성장조절체, 비료, 토양개선제등과의 혼합물로도 사용될 수 있다.This agent is administered directly to the soil or plant, either by itself or diluted, for example with water. More specifically, they are administered in various forms, for example, by spraying or dusting on plants, spraying on soil surfaces, dust or granule-sprinkleing or, if necessary, secondary soiling. In addition, when using this formulation as a seed treatment, the seed is covered or submerged in this formulation. The formulations may also be used in admixture with other fungicides, pesticides, mites, pesticides, herbicides, plant growth regulators, fertilizers, soil improvers and the like.
본 발명의 화합물은 논, 경작지, 과수원, 목초지, 잔디 등에 사용도리 살진균제의 활성성분으로 사용된다. 본 발명의 화합물을 살진균제의 활성 성분으로 사용할때, 그 투여량은 날씨조건, 제제형, 시간, 투여방법 및 장소, 억제될 질병, 처리도리 곡물에 따 지만 통상 아르당 0.5내지 100g, 바람직하게는 1내지 50g이다. 유화농축액, 습식분말 현탁제제, 약체제제등을 사용하기 위해 물로 희석했을 때의 농도는 0.0001% 내지 1%, 바람직하게는 0.0005% 내지 0.5%이다. 과립제 및 분진은 희석되지 않고 사용된다.The compounds of the present invention are used as active ingredients of fungicides used in rice fields, arable land, orchards, grasslands, grasses and the like. When the compound of the present invention is used as an active ingredient of a fungicide, the dosage is usually 0.5 to 100 g per ar, depending on weather conditions, preparation type, time, method and place of administration, disease to be suppressed and processed grains, preferably 1 to 50 g. The concentration at the time of dilution with water in order to use an emulsion concentrate, a wet powder suspension preparation, a pharmaceutical preparation, etc., is 0.0001%-1%, Preferably it is 0.0005%-0.5%. Granules and dusts are used without dilution.
본 발명의 화합물은 각종 식물질병, 특히 바시디오미세트류에 속하는 세균에 의한 것에 대해 특히 효과적이어서 본 발명의 화합물은 각종 투여용 살진균제의 활성 성분으로 사용될 수 있다.The compounds of the present invention are particularly effective against various plant diseases, particularly those caused by bacteria belonging to bacidiomycetes, so that the compounds of the present invention can be used as active ingredients of fungicides for various administrations.
본 발명은 하기 합성에, 참고예, 제제예 및 시험예에 의해 더욱 자세히 설명된다.The present invention is explained in more detail by reference examples, formulation examples and test examples in the following synthesis.
합성예 1[방법(A)로 화합물(2)합성]Synthesis Example 1 [Synthesis of Compound (2) by Method (A)]
테트라히드로푸란 5ml에 용해시킨 1,1,3-트리메틸-2-옥사-4-아미노인단 80mg 및 트리에틸아민 50mg 용액에 교반하면서 빙냉하 내부 온도 5℃이하에서 테트라히드로푸란 2ml에 용해시킨 5-클로로-1,3-디메틸피라졸-4-카르보닐클로라이드 89mg을 적가한 후, 실온에서 하룻밤 교반한다. 반응 혼합물을 물 및 클로로포름으로 추출한다.5 mg of 1,1,3-trimethyl-2-oxa-4-aminoindane dissolved in 5 ml of tetrahydrofuran and 50 mg of triethylamine were dissolved in 2 ml of tetrahydrofuran at 5 ° C. or lower under ice-cooling with stirring. 89 mg of chloro-1,3-dimethylpyrazole-4-carbonyl chloride is added dropwise, followed by stirring at room temperature overnight. The reaction mixture is extracted with water and chloroform.
유기층을 물로 세척하고, 건조하고, 농축한다. 잔류물을 실리카겔 박막 크로마토그래피로 정제하여 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-5-클로로-1,3-디메틸피라졸-4-카르복사미드 119mg을 수득한다.The organic layer is washed with water, dried and concentrated. The residue was purified by silica gel thin layer chromatography to give 119 mg of N- (1,1,3-trimethyl-2-oxa-4-indanyl) -5-chloro-1,3-dimethylpyrazole-4-carboxamide. To obtain.
합성예 2[방법(A)로 화합물(13)합성]Synthesis Example 2 [Synthesis of Compound (13) by Method (A)]
테트라히드로푸란 5ml에 용해시킨 1,1,3-트리메틸-3-옥사-4-아미노인단 70mg 및 트리에틸아민 44mg 용액에 빙냉하 5℃이하의 온도에서 교반하에서 테트라히드로푸론 2ml에 용해시킨 2-(트리플루 오토메틸)벤조일클로라이드 83mg용액을 적가한후, 실온에서 하룻밤 교반한다. 그런 후, 반응 혼합물을 물 및 클로로포름으로 추출한다. 유기층을 5%염산 및 물로 세척하고, 건조하고, 능축한다. 잔류물을 실리카겔 박막 크로마토그래피로 정제하여 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-2-(트리폴루오토메틸)벤즈아미드 102mg을 수득한다.2-mg of 1,1,3-trimethyl-3-oxa-4-aminoindane dissolved in 5 ml of tetrahydrofuran and 44 mg of triethylamine were dissolved in 2 ml of tetrahydrofuron under stirring at a temperature of 5 ° C. under ice cooling. A solution of 83 mg of (triflu automethyl) benzoyl chloride is added dropwise, followed by stirring at room temperature overnight. The reaction mixture is then extracted with water and chloroform. The organic layer is washed with 5% hydrochloric acid and water, dried and biaxially. The residue is purified by silica gel thin layer chromatography to give 102 mg of N- (1,1,3-trimethyl-2-oxa-4-indanyl) -2- (tripolotomethyl) benzamide.
합성예 3[방법(A)로 화합물(19)합성]Synthesis Example 3 [Synthesis of Compound (19) by Method (A)]
메틸렌클로라이드 10ml에 용해시킨 2-메틸니코틴산 155mg 및 1-(3-디메틸아미노프로필)-3-에틸카르보디이미드 매티오 디드 335mg 용액을 1시간 실온에서 교반한다.A solution of 155 mg of 2-methylnicotinic acid and 335 mg of 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide matiodide dissolved in 10 ml of methylene chloride is stirred at room temperature for 1 hour.
용액에 1,1,3-트리메틸-2-옥사-4-아미노인단 200mg을 거하고 반응을 환류하 6시간 진행한다. 반응 혼합물에 메틸렌클로라이드 및 물을 가하여 유기층을 추출한다. 유기층을 농축하고 실리카겔 박막크로마토그래피로 정제하여 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-2-메틸니코틴아미드를 수득한다.200 mg of 1,1,3-trimethyl-2-oxa-4-aminoindane was added to the solution, and the reaction proceeded under reflux for 6 hours. Methylene chloride and water are added to the reaction mixture to extract the organic layer. The organic layer was concentrated and purified by silica gel thin layer chromatography to give N- (1,1,3-trimethyl-2-oxa-4-indanyl) -2-methylnicotinamide.
합성예 4[방법(A)로 하하불 (24)]합성Synthesis Example 4 Synthesis by Method (A)
테트라히드로푸란 5ml에 용해시킨 1,1,3-프리메틸-2-옥사-4-아민인단 100mg및 트리에틸아민 63mg 용액에 트르라히드로푸란 2ml에 용해시킨 2-메틸-4-트리플루 오로메틸이줄-5-카르보닐클로라이드 130mg용액을 빙냉하 5℃이하의 내부 온도에서 교반하게 가한다. 적가한, 반응 혼합물을 실온에서 하룻밤 교반하고, 물 및 클로로포름으로 추출한다. 유기층을 5%염산 및 물로 세척하고, 건조하고, 농축한다.100 mg of 1,1,3-premethyl-2-oxa-4-amine indane dissolved in 5 ml of tetrahydrofuran and 63 mg of triethylamine in 2-methyl-4-trifluuromethyl dissolved in 2 ml of tralahydrofuran 130 mg of this Joule-5-carbonyl chloride solution is added to the mixture with stirring at an internal temperature of 5 ° C. or less under ice cooling. The dropwise addition, the reaction mixture is stirred overnight at room temperature and extracted with water and chloroform. The organic layer is washed with 5% hydrochloric acid and water, dried and concentrated.
잔류물을 실리카겔 박막 크로마토그래피로 정제하여 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-2-메틸-4-트리풀루오로메릴티아졸-5-카르복사미드 172mg을 수득한다.The residue was purified by silica gel thin film chromatography to give N- (1,1,3-trimethyl-2-oxa-4-indanyl) -2-methyl-4-trifluoromerylthiazole-5-carboxamide 172 mg are obtained.
합성예 5[방법(A)로 화합물(26)합성]Synthesis Example 5 [Synthesis of Compound (26) by Method (A)]
테트라히드로푸란 10ml에 용해시킨 티오아세트아미트 49mg 및 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-2-클로로아세토아세트아미드 193mg용액을 환류하 3시간 반응시킨다.49 mg of thioacetamide and 193 mg of N- (1,1,3-trimethyl-2-oxa-4-indanyl) -2-chloroacetoacetamide dissolved in 10 ml of tetrahydrofuran were reacted under reflux for 3 hours.
반응 혼합물에 무수탄산칼륨 90mg을 가하고 혼합물을 환류하 4시간 반응시킨다. 유기층을 건조화고, 농축하고, 실리카겔 박막 크로마토그래피로 정제하여 N-(1,1,3-트리메틸-2-옥사-4-인다닐)-2,4-디메틸티아졸-5-카르복사미드 89mg을 수득한다.90 mg of anhydrous potassium carbonate is added to the reaction mixture, and the mixture is reacted under reflux for 4 hours. The organic layer was dried, concentrated and purified by silica gel thin layer chromatography to give 89 mg of N- (1,1,3-trimethyl-2-oxa-4-indanyl) -2,4-dimethylthiazole-5-carboxamide. To obtain.
이 방법으로 수득될 수 있는 본 발명의 몇몇 대표적인 화합물로 표1에 나타낸다.Some representative compounds of the invention that can be obtained by this method are shown in Table 1.
[표 1]TABLE 1
하기식으로 표시되는 화합물Compound represented by the following formula
합성예 6[방법(B)로 화합물(29)합성]Synthesis Example 6 Synthesis of Compound (29) by Method (B)
테트라히드포푸란 10ml에 용해시킨(3S)-1,1,3-트리메틸-2-옥사-4-아미노인단 160mg및 피리딘 79mg 용액에 페트라히로부탄 4ml에 용해시킨 5-클로로-1,3-디메틸피라졸-4-카르보닐클로라이드 178mg 용액을 빙냉하 내부 온도 5℃이하에서 교반하며 적가한 후, 실온에서 하룻밤 고반한다. 물 및 클로로포름으로 추출한다. 유기층을 1% 염산으로 세척하고, 건조하고 농축된다. 잔류물을 실리카겔 박막크로마토그래피로 정제하여 N-[(3S)-1,1,3-트리메틸-2-옥사-4-인디닐)-5-클로로-1,3-디메틸피라졸-4-카르복사미드 262mg(수율 67%)을 수득한다.160 mg of (3S) -1,1,3-trimethyl-2-oxa-4-aminoindan and 79 mg of pyridine dissolved in 10 ml of tetrahydrophorfuran and 4-chloro-1,3-dimethyl dissolved in 4 ml of petrihirobutane. A 178 mg solution of pyrazole-4-carbonyl chloride is added dropwise with stirring at an internal temperature of 5 ° C. or lower under ice cooling, followed by overnight at room temperature. Extract with water and chloroform. The organic layer is washed with 1% hydrochloric acid, dried and concentrated. The residue was purified by silica gel thin layer chromatography to give N-[(3S) -1,1,3-trimethyl-2-oxa-4-indinyl) -5-chloro-1,3-dimethylpyrazole-4-car 262 mg (yield 67%) of copyamide are obtained.
합성예 7[방법(D)로 화합물(29)합성]Synthesis Example 7 Synthesis of Compound (29) by Method (D)
N-(1,1,3-트리메틸-2-옥사-4-인다닐)-5-클로로-1,3-디메틸피라졸-4-카르복사미드를 "수미팩오에이"-4100 광학 활성 컬럼[용리액 ; 헥산 : 1,2-디클로로에탄 : 에탄올=500 : 150 : 1.5]로 거울상 이성체로 분리한다. 바람직한N-[(3S)-1,1,3-트리메틸-2-옥사-4-인다닐]-5-클로로-1,3-디메틸피라졸-4-카르복사미드가 전방 피크로서 용리된다(수율 : 38%)N- (1,1,3-trimethyl-2-oxa-4-indanyl) -5-chloro-1,3-dimethylpyrazole-4-carboxamide was added to "Sumipac OA" -4100 optically active column [ Eluent; Hexane: 1,2-dichloroethane: ethanol = 500: 150: 1.5]. Preferred N -[(3S) -1,1,3-trimethyl-2-oxa-4-indanyl] -5-chloro-1,3-dimethylpyrazole-4-carboxamide elutes as forward peak ( Yield: 38%)
상기 합성예로 수득한 본 발명의 화합물(29)는 하기 특성을 나타낸다 :Compound (29) of the present invention obtained by the above synthesis example exhibits the following properties:
융점 169.1℃Melting Point 169.1 ℃
t16 =-74.3°(CHCl3, c 1.0)t16 = -74.3 ° (CHCl 3 , c 1.0)
식(IV)로 표시되는 치환 4-아미노-2-옥사인단의 제조 방법을 하기에 설명한다.The manufacturing method of substituted 4-amino- 2-oxane group represented by Formula (IV) is demonstrated below.
참고예 1Reference Example 1
α,α-디메틸-2-히드록시메틸-3-아세트아미노벤질 알코올 합성α, α-dimethyl-2-hydroxymethyl-3-acetaminobenzyl alcohol synthesis
금속마그네슘 9.5g 및 디에틸에테르 60ml의 혼합물에 디에틸에테르 120ml에 용해시킨 메틸요오다이드 56g 용액을 교반하여 서서히 가한다. 혼합용액을 감압하 15분간 가열하고 냉각한다. 상기 이렇게 제조한 에테르내에 용해시킨 메틸마그네슘 요오다이드 용액을 테트라히드로푸란 120ml에 용해시킨 4-아세트아미노프탈리드 7.5g용액에 10℃ 이하의 내부 온도에서 교반하여 서서히 가한 후, 실온에서 하룻밤 교반한다. 반응이 완결된 후, 반응 혼합물을 빙냉하에서 암모늄클로라이드 수용액(포화)에 붓고 에틸아세테이트 400ml로 2회 추출한다. 조합한 추출물을 건조하고, 농축하여 유상물질을 수득한다. 유상물질을 실리카겔컬럼크로마토그래피로 정제하여 α,α-디메틸-2-히드록시메틸-3-아세트아미노벤질알코올 7.2g을 백색결정형으로 수득한다. 융점 137.9℃To a mixture of 9.5 g of metal magnesium and 60 ml of diethyl ether, a 56 g solution of methyl iodide dissolved in 120 ml of diethyl ether was slowly added with stirring. The mixed solution is heated and cooled under reduced pressure for 15 minutes. The methyl magnesium iodide solution dissolved in the ether thus prepared was slowly added to 7.5 g of 4-acetaminophthalide dissolved in 120 ml of tetrahydrofuran by stirring at an internal temperature of 10 ° C. or lower, and then stirred overnight at room temperature. do. After the reaction was completed, the reaction mixture was poured into an aqueous ammonium chloride solution (saturated) under ice cooling and extracted twice with 400 ml of ethyl acetate. The combined extracts are dried and concentrated to yield an oily substance. The oily substance was purified by silica gel column chromatography to obtain 7.2 g of α, α-dimethyl-2-hydroxymethyl-3-acetaminobenzyl alcohol as a white crystalline form. Melting Point 137.9 ℃
1H-NHR(CDC13)δppm 1 H-NHR (CDC1 3 ) δppm
1.6(6H, s), 2.1(3H, s), 3.7(2H, br s), 5.0(2H, s), 7.2~7.8(3H, m), 8.7(1H, br s)1.6 (6H, s), 2.1 (3H, s), 3.7 (2H, br s), 5.0 (2H, s), 7.2-7.8 (3H, m), 8.7 (1H, br s)
참고예 2Reference Example 2
3,3-디메틸-7-아세트아미노프탈리드 합성3,3-dimethyl-7-acetaminophthalide synthesis
클로로포름 300ml에 용해시킨 α,α-디메틸-2-히드록시메틸-3-아세트아미노벤질알코올 7.2g 용액을 활성 이산화망간 28g을 가하고 혼합물을 환류하에서 6식간 반응시킨다. 반응이 완결된 후, 반응 혼합물을 냉각하기 위해 방치학고, 셀리트베드를 갖는 유리여과기에 여과한다. 잔류물을 클로로포름 100ml로 세척한다. 여액 및 세척 용액을 조합하고 농축하여 유상물질을 수득한다. 유상물질을 실리카겔 컬럼크로마토그래피로 정제하여 백색 결정형으로 3,3-디메틸-7-아세트아미노프탈리드 4,4g을 수독한다. 융점 124.1℃A solution of 7.2 g of α, α-dimethyl-2-hydroxymethyl-3-acetaminobenzyl alcohol dissolved in 300 ml of chloroform was added to 28 g of active manganese dioxide and the mixture was reacted for 6 meals under reflux. After the reaction is complete, the reaction mixture is left to cool and filtered in a glass filter with a celite bed. The residue is washed with 100 ml of chloroform. The filtrate and wash solution are combined and concentrated to yield an oily substance. The oily substance is purified by silica gel column chromatography to obtain 4,4 g of 3,3-dimethyl-7-acetaminophthalide as a white crystalline form. Melting Point 124.1 ℃
1H-NMRδppm 1 H-NMRδppm
1.6(6H, s), 2.2(3H, s), 7.0(1H, d, J=8.0Hz), 7.6(1H, t, J=8.0Hz), 8.5(1H, d, J=8.0Hz), 9.7(1H, br s)1.6 (6H, s), 2.2 (3H, s), 7.0 (1H, d, J = 8.0 Hz), 7.6 (1H, t, J = 8.0 Hz), 8.5 (1H, d, J = 8.0 Hz), 9.7 (1H, broad singlet)
참고예 3Reference Example 3
1,1,3-트리메틸-3-히드록시-2-옥사-4-아세트 아미노인단 합성1,1,3-trimethyl-3-hydroxy-2-oxa-4-acetaminoindan synthesis
테트라히드로푸탄 80ml에 용해시킨 3,3-디메틸-7-아세트아미노프탈리드 4.4g 용액에 에테르에 용해시킨 메틸리튬용액(1.4M)43ml을 -20℃에서 적가한 후 동온도에서 20분간 교반한다. 반응이 완결된 후, 반응 혼합물을 빙냉하에서 암모늄클로라이드 수용액(포화)에 붓고 에틸아세테이프 200ml로 2회 추출한다. 조합한 추출물을 건조하고, 농축하여 1,1,3-트리메틸-3-히드록시-2-옥사-4-아세트아미노인단 4.7g을 유상물질로 수득한다.To a 4.4 g solution of 3,3-dimethyl-7-acetaminophthalide dissolved in 80 ml of tetrahydrobutane, 43 ml of a methyllithium solution (1.4M) dissolved in ether was added dropwise at -20 ° C, followed by stirring for 20 minutes at the same temperature. do. After the reaction was completed, the reaction mixture was poured into an aqueous ammonium chloride solution (saturated) under ice cooling and extracted twice with 200 ml of ethyl acetate. The combined extracts were dried and concentrated to give 4.7 g of 1,1,3-trimethyl-3-hydroxy-2-oxa-4-acetaminoindan as an oily substance.
1H-NMRδppm 1 H-NMRδppm
1.5(6H, s), 1.7(3H, s), 2.1(3H, br s), 4.7(1H, s), 6.85(1H, d, J=8.0Hz), 7.3(1H, t, J=8.0Hz), 7.9(1H, d, J=8.0Hz), 8.0(1H, s)1.5 (6H, s), 1.7 (3H, s), 2.1 (3H, br s), 4.7 (1H, s), 6.85 (1H, d, J = 8.0 Hz), 7.3 (1H, t, J = 8.0 Hz), 7.9 (1H, d, J = 8.0 Hz), 8.0 (1H, s)
참고예 4Reference Example 4
1,1,3-트리메틸-2-옥사-4-아세트아미노인단 합성1,1,3-trimethyl-2-oxa-4-acetaminoindane synthesis
에탄올 120ml에 용해시킨 1,13-트리메틸-3-히드록시-2-옥사-4-아세트아미노인단 4.7g 용액에 농염산 및 10%팔라듐 카아본 촉매량을 가하고 둥온도에서 수소분위기하에서 6시간 격력하게 교반한다. 반응이 완결된 후 반응 혼합물을 셀리트베드를 갖는 유리여과기에 여과하고 잔류물을 에탄올 60ml로 세척한다. 여액 및 세척용액을 조합하고 1,1,3-트리메틸-2-옥사-4-아세트아미노인단 4.3g을 유상물질형으로 수득한다.To a 4.7 g solution of 1,13-trimethyl-3-hydroxy-2-oxa-4-acetaminoinane dissolved in 120 ml of ethanol was added the amount of concentrated hydrochloric acid and 10% palladium carbon, and vigorously stirred for 6 hours under hydrogen atmosphere at room temperature. Stir. After the reaction is completed, the reaction mixture is filtered through a glass filter with a celite bed and the residue is washed with 60 ml of ethanol. The filtrate and washing solution are combined and 4.3 g of 1,1,3-trimethyl-2-oxa-4-acetaminoindane is obtained in the form of an oily substance.
1H-NMRδppm 1 H-NMRδppm
1.4(3H, s), 1.4(3H, d, J=6.0Hz), 1.5(3H, s), 2.1(3H, s), 5.4(1H, q, J=6.0Hz), 6.8~7.4(3H, m), 8.1(1H, s)1.4 (3H, s), 1.4 (3H, d, J = 6.0 Hz), 1.5 (3H, s), 2.1 (3H, s), 5.4 (1H, q, J = 6.0 Hz), 6.8-7.4 (3H , m), 8.1 (1H, s)
합성예 8Synthesis Example 8
1,1,3-트리메틸-2-옥사-4-아미노인당 합성Synthesis of 1,1,3-trimethyl-2-oxa-4-aminophosphate
에틸렌글리콜 60ml 및 물 30ml에 용해시킨 1,1,3-트리메틸-2-옥사-4-아세트아미노인단4.3g 용액에 수산화 칼륨 11g을 가하고 혼합물을 환류하 6시간 질소분위기하에서 가열한다. 반응이 완결된 후, 반응 혼합물을 방치하여 냉각하고 물 60ml로 희석하고, 클로로포름 60ml로 4회추출한다. 조합한 추출물을 물로 3회 세척하고 건조하고 농축한다. 수득한 유상물질을 실리카겔박막크로마토그래피로 정제하여 1,1,3-트리메틸-2-옥사-4-아미노인단 2.0g을 백색 결정형으로 수득한다. 융점 75.5℃To a 4.3 g solution of 1,1,3-trimethyl-2-oxa-4-acetaminoindan dissolved in 60 ml of ethylene glycol and 30 ml of water, 11 g of potassium hydroxide was added and the mixture was heated under reflux for 6 hours under nitrogen atmosphere. After the reaction was completed, the reaction mixture was left to cool, diluted with 60 ml of water, and extracted four times with 60 ml of chloroform. The combined extracts are washed three times with water, dried and concentrated. The obtained oily substance was purified by silica gel thin layer chromatography to obtain 2.0 g of 1,1,3-trimethyl-2-oxa-4-aminoindan as a white crystalline form. Melting Point 75.5 ℃
1H-NMRδppm 1 H-NMRδppm
1.4(3H, s), 1.5(3H, d, J-6.0Hz), 1.5(3H, s), 3.6(2H, br s), 5.25(1H, q, J=6.0Hz), 6.2~6.7(2H, m), 7.1(1H, dd, 각각 J=6.0Hz)1.4 (3H, s), 1.5 (3H, d, J-6.0 Hz), 1.5 (3H, s), 3.6 (2H, br s), 5.25 (1H, q, J = 6.0 Hz), 6.2-6.7 ( 2H, m), 7.1 (1H, dd, J = 6.0 Hz each)
합성예 9Synthesis Example 9
1,1-디메틸-3-에틸-2-옥사-4-아미노인단을 합성예 6과 유사한 방법으로 수득한다.1,1-dimethyl-3-ethyl-2-oxa-4-aminoindane is obtained by a method similar to Synthesis Example 6.
1H-NMRδppm 1 H-NMRδppm
1.0(3H, t, J=6.0Hz), 1.45(3H, s), 1.55(3H, s), 1.4~2.1(2H, m), 3.5(2H, br s,), 5.15(1H, dd, J=6.0Hz, 4.0Hz), 6.45(2H, br d), 7.0(1H, dd, J=8.0Hz, J=6.0Hz)1.0 (3H, t, J = 6.0 Hz), 1.45 (3H, s), 1.55 (3H, s), 1.4-2.1 (2H, m), 3.5 (2H, br s,), 5.15 (1H, dd, J = 6.0 Hz, 4.0 Hz), 6.45 (2H, br d), 7.0 (1H, dd, J = 8.0 Hz, J = 6.0 Hz)
학기는 제제예이며, 여기서 사용한 본 발명의 화합물은 표 1및 합성예에서 주어진 번호로 나타낵고 부는 중량을 기준으로 한다.The semester is a formulation example, and the compounds of the present invention used herein are based on the weight given and indicated by the numbers given in Table 1 and the synthesis examples.
제제예 1Formulation Example 1
본 발명의 화합물 (1)~(29)각각 50부, 칼슘릭그노술포네이트 3부, 소듐라우릴술페이트 2부 및 합성수화 이산확규소 45부를 완전히 미분쇄학고 혼합하여 활성성분 농도 50%를 함유하는 습식분말을 수득50 parts of each of the compounds (1) to (29) of the present invention, 3 parts of calcium lignosulfonate, 2 parts of sodium lauryl sulfate and 45 parts of synthetic hydrated silicon dioxide were thoroughly ground and mixed to obtain 50% of the active ingredient concentration. Obtaining wet powder containing
제제예 2Formulation Example 2
본 발명의 화합물 (1)~(29) 각각 10부, 폴리옥시에틸렌스티릴페닐에테로 14부, 칼슘 도데실벤젠술포네이트 6부 및 크실렌70부를 완전히 혼합하여 활성 성분 농도 10%를 갖는 유화 농축액을 수득한다.Emulsion concentrate having 10% of active ingredient concentration by thoroughly mixing 10 parts of compounds (1) to (29) of the present invention, 14 parts of polyoxyethylene styrylphenyl ether, 6 parts of calcium dodecylbenzenesulfonate and 70 parts of xylene To obtain.
제제예 3Formulation Example 3
본 발명의 화합물 (1)~(29) 각각 2부, 합성 수화 이산화규소 1부, 칼슘 리그노술포네이트 2부, 벤토나이트 30부 및 카올린클레이 65부를 완전히 미분쇄하고 혼합학고 물로 잘 반죽한 후 과립화하고 건조하여 활성 성분 농도 2%를 갖는 과립제를 수득한다.2 parts of the compounds (1) to (29) of the present invention, 1 part of synthetic hydrated silicon dioxide, 2 parts of calcium lignosulfonate, 30 parts of bentonite, and 65 parts of kaolin clay were thoroughly pulverized and kneaded well with water and then granulated. And dry to obtain granules having an active ingredient concentration of 2%.
제제예 4Formulation Example 4
본 발명의 화합물 (1)~(29)각각 25부, 폴리옥시에틸렌소르비탄모노올레에이트 3부, CMC 3부 및 물69부를 혼합학고 습식분쇄하여 5미크론 이하의 입자 크기를 만들어 활성 성분 농도 25%를 갖는 현탁제제를 수득한다.25 parts of compounds (1) to (29) of the present invention, 3 parts of polyoxyethylene sorbitan monooleate, 3 parts of CMC, and 69 parts of water were mixed and wet-pulverized to obtain a particle size of 5 microns or less, and an active ingredient concentration of 25 A suspension with% is obtained.
제제예 5Formulation Example 5
본 발명에 화합물 (1)~(29) 각각 2부, 카올린클레이 66부 및 활석 10부를 완전히 미분쇄하고 혼합하여 활성성분 농도 2%를 갖는 분전을 수득한다.In the present invention, 2 parts of compounds (1) to (29), 66 parts of kaolin clay and 10 parts of talc are completely ground and mixed to obtain a powder having an active ingredient concentration of 2%.
제제예 6Formulation Example 6
본 발명의 화합물 (1)~(29) 각각 10부, 폴리옥시에 틸렌스티릴페닐에테르 1부 및 물 89부를 혼합하여 활성성분 농 10%를 갖는 애게츨 수득한다.10 parts of compounds (1) to (29) of the present invention, 1 part of polyoxy ethylene styryl phenyl ether, and 89 parts of water are mixed to obtain an aggregate having 10% of the active ingredient concentration.
본 발명의 화합물이 살균제의 활성 성분으로서의 효과를 하기 시험예로 나타낸다. 사용한 본 발명의 화합물은 표1 및 합성예에서 주어진 화합물 번호로 표시하고, 대조용으로 사용한 화합물은 표2에 주어진 화합물을 표시한다.The compound of the present invention shows the effect of the fungicide as an active ingredient in the following test example. The compound of the present invention used is indicated by the compound number given in Table 1 and Synthesis Example, and the compound used as a control indicates the compound given in Table 2.
[표 2]TABLE 2
퇴치효과를 관찰하는 시험식물의 질병의 상태, 즉 균류의 정도 및 일 및 줄기의 감염 영역을 육안으로 관측하고 질병의 상태를 하기 여섯지수 0,1,2,3,4 및 5로 측정하여 결정한다.Determine the disease state of the test plant, ie the degree of fungus and the area of infection of the stem and stem, and the state of the disease by measuring the following six indexes 0,1,2,3,4 and 5 do.
5…감염 영역 및 균류 없음.5... No area of infection and fungus.
4…감염 영역 및 균류가 잎 및 줄기의 약 10%에서 관측됨.4… Areas of infection and fungi are observed in about 10% of the leaves and stems.
3…감염영역 및 균류가 잎 및 줄기의 약 30%에서 관측됨.3... Infection areas and fungi are observed in approximately 30% of the leaves and stems.
2…감염영역 및 균류가 잎 및 줄기의 약 50%에서 관측됨.2… Infection areas and fungi are observed in approximately 50% of the leaves and stems.
1…감염 영역 및 균류가 잎 및 줄기의 약 70%에서 관측됨.One… Areas of infection and fungi are observed in approximately 70% of the leaves and stems.
0…감염 영역 및 균류가 약 70%이상 관측되고 화합물을 사용했을 때 질병 상태의 변화를 인식할 수 없음.0… Over 70% of areas of infection and fungi are observed, and changes in disease status are not recognized when the compounds are used.
상기 측정을 하기 시험에 전부에 적용한다.The measurements apply to all of the following tests.
시험예 1 벼의 엽초 고사병(리족토니아 솔라니)에 대한 방지퇴치 효과 시험Test Example 1 Effect of preventing eradication against the foliar plaque of rice plant (Lytononia solani)
플라스틱포트에 모래 양토를 채우고 벼(변종 : 깅끼 33호)를 파종하고 20일간 온실에서 20일간 경작하여 4-5일 단계의 식물로 성장시킨다. 시험 화합물을 제제예 2에 따라 유화농축액으로 제제하고 물로 희석하여 주어진 농도로 한다.Fill a plastic pot with sandy loam, plant rice (variety: Gingki No. 33), and cultivate in a greenhouse for 20 days for 20 days to grow into plants of 4-5 days. The test compound is prepared in emulsion concentrate according to Formulation Example 2, diluted with water to a given concentration.
식물에 이것을 잎-분사하여 일 표면에 완전히 퇴적되도록 한다. 분사로부터 4시간후, 식물을 리족토니아솔라니를 함유하는 한천조각으로 접종한다. 접종한 후, 식물을 매우 습한 조건하에서 4일간 28℃ 에서 성장시키고 억제효과를 관측한다. 결과를 표 3에 나타낸다.The plant is leaf-sprayed so that it is completely deposited on one surface. After 4 hours from spraying, the plants are inoculated with agar pieces containing liqanthoniasolani. After inoculation, the plants are grown at 28 ° C. for 4 days under very humid conditions and the inhibitory effect is observed. The results are shown in Table 3.
[표 3]TABLE 3
시험예 2 벼의 엽초 고사병(리족토니아 솔라니)에 대한 체계적인 퇴치 효과 시험Test Example 2 Systematic Fighting Effect Test of Rice Leaf Death Disease (Lygitonia solani)
130ml플라스틱포트에 모래 양토를 채우고 벼(변종 : 깅끼33호)를 파종하고 3주일간 온실에서 경작하여 4-5일 단계의 식물로 성장시킨다. 시험 화합물을 제제에 1에 따라 습식분말로 제제하고 물로 희석하고 토양에 주어진 양으로 살포한다. 살포 후, 식물을 7일간 온실에서 성장시키고 리족토니아 솔라니를 함유하는 한천 조각으로 접종한댜. 접종 후, 식물을 매우 습한조건하에서 4일간 28℃ 에서 성장시키고 억제효과를 측정한다. 결과를 표 4에 나타낸다.Fill a 130 ml plastic pot with sandy loam, sow rice (variety: Gingki 33), and cultivate in a greenhouse for 3 weeks to grow into plants of 4-5 days. The test compound is formulated in wet powder according to 1 into the formulation, diluted with water and sprayed in the soil in a given amount. After spraying, the plants were grown in greenhouses for 7 days and inoculated with agar pieces containing lizartonia solani. After inoculation, plants are grown at 28 ° C. for 4 days under very humid conditions and the inhibitory effect is measured. The results are shown in Table 4.
[표 4]TABLE 4
시험예 3 강나콩의 서던 고조병(코르티슘 롤프시이)에 대한 퇴치 효과 시험Test Example 3 Test for eradication effect of southern coriander (Cortisium Rolfsey)
밀기울 배치에서 미리 배양된 코르티슘 롤프시이로 잘 혼합된 모래 양토를 250ml플라스틱포트에 채우고 강남콩(변종 : 다이쇼킨도끼)를 파종한다. 시험 화합물을 제제예 1에 따라 습식 분말로 제제하고 물로 희석한다. 시험 화합물의 주어진 양을 토양에 살포한다. 살포 후, 온실에서 3주간 경작하고 억제효과를 토양표면근처에 있는 줄기의 질병 정도를 관찰하여 시험한다. 결과를 표5에 나타낸다.Fill a 250 ml plastic pot with well-mixed sandy loam with a pre-cultivated Cortium Rolf Seed in a bran batch and seed the Gangnam beans. Test compounds are formulated into wet powders according to Formulation Example 1 and diluted with water. A given amount of test compound is sprayed onto the soil. After spraying, cultivate in the greenhouse for 3 weeks and test the inhibitory effect by observing the degree of disease of the stem near the soil surface. The results are shown in Table 5.
[표 5]TABLE 5
시험예 4 밀의 갈색 녹병(푸치니아 레콘디타)에 대한 치료퇴치효과시험Test Example 4 Effect of Treatment Eradication on Brown Rust Disease (Puccinia Recondita)
모래양토를 플라스틱포트에 채우고 밀(변종 : 노린73호)를 파종하고 10일간 온실에서 성장시켜 2-3일 단계의 식물이 되고, 이것을 푸치니아 레콘디타의 포자로 접종한다. 접종 후, 식물을 매우 습한 조건하에서 1일간 23℃에서 성장시키고, 이 식물에 제제에 2에 따라 유화농축액으로 제제되고 물로 희석하여 주어진 농도로 만든 시험 화합물을 잎-분사하여 화합물을 잎 표면에 완전히 퇴적시킨다. 분사후, 식물을 조명하에서 7일간 23℃에서 성장시킥고 억제 효과를 관측한다. 결과를 표6에 나타낸다.Fill the sandy loam with a plastic pot, sow wheat (variety: Norin 73), grow in a greenhouse for 10 days, become a 2-3-day plant, and inoculate it with spuccinia of Puccinia recondita. After inoculation, the plants are grown at 23 ° C. for 1 day under very humid conditions, and the plants are prepared as emulsified concentrates according to Formula 2 and diluted with water to leaf-inject the test compound made at a given concentration to completely dissolve the compound on the leaf surface. To be deposited. After spraying, the plants were grown at 23 ° C. for 7 days under illumination and the inhibitory effect was observed. The results are shown in Table 6.
[표 6]TABLE 6
Claims (14)
Applications Claiming Priority (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28156487 | 1987-11-06 | ||
| JP281564/87 | 1987-11-06 | ||
| JP281563/87 | 1987-11-06 | ||
| JP28156587 | 1987-11-06 | ||
| JP28156387 | 1987-11-06 | ||
| JP281565/87 | 1987-11-06 | ||
| JP17775188 | 1988-07-15 | ||
| JP177751/88 | 1988-07-15 | ||
| JP191920/88 | 1988-07-29 | ||
| JP63191920A JPH01230569A (en) | 1987-11-06 | 1988-07-29 | Substituted carboxylic acid derivative, its production and agricultural and horticulatural fungicide containing said derivative as active component |
| JP19191988A JP2638966B2 (en) | 1987-11-06 | 1988-07-29 | Substituted thiazolecarboxylic acid derivatives and agricultural and horticultural fungicides containing the same as active ingredients |
| JP191919/88 | 1988-07-29 | ||
| JP193598/88 | 1988-08-02 | ||
| JP19359888A JP2638968B2 (en) | 1987-11-06 | 1988-08-02 | Substituted pyrazolecarboxylic acid derivatives, agricultural and horticultural fungicides and intermediates containing the same as active ingredients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR890008133A KR890008133A (en) | 1989-07-08 |
| KR970011303B1 true KR970011303B1 (en) | 1997-07-09 |
Family
ID=68158445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880014526A Expired - Lifetime KR970011303B1 (en) | 1987-11-06 | 1988-11-05 | Substituted carboxylic acid derivatives, process for preparing the same and agricultural or horiticultural fungicides containing the same |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR970011303B1 (en) |
-
1988
- 1988-11-05 KR KR1019880014526A patent/KR970011303B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR890008133A (en) | 1989-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0276177B1 (en) | Heterocyclic derivatives, method for their preparation and fungicides containing them as active ingredients | |
| EP0315502B1 (en) | Substituted carboxylic acid derivatives, processes for preparing the same and agricultural or horticultural fungicides containing the same | |
| KR0131326B1 (en) | Substituted quinolines and cinnolines | |
| JP2000053670A (en) | Alkoxymethylfuranone derivatives and pesticides | |
| JPH064594B2 (en) | Pyrazolcarboxamide derivative and fungicide containing the same as an active ingredient | |
| US4839378A (en) | Fluorophthalimides and agricultural and horticultural fungicides containing them | |
| KR970011303B1 (en) | Substituted carboxylic acid derivatives, process for preparing the same and agricultural or horiticultural fungicides containing the same | |
| JP2638968B2 (en) | Substituted pyrazolecarboxylic acid derivatives, agricultural and horticultural fungicides and intermediates containing the same as active ingredients | |
| US5049575A (en) | Substituted carboxylic acid, fungicidal compositions and use | |
| JP2638966B2 (en) | Substituted thiazolecarboxylic acid derivatives and agricultural and horticultural fungicides containing the same as active ingredients | |
| JP2552846B2 (en) | Substituted thiazolecarboxylic acid derivatives and agricultural and horticultural fungicides containing the same as active ingredients | |
| JP2625871B2 (en) | Substituted dihydropyrancarboxylic acid derivatives and agricultural and horticultural fungicides containing the same as active ingredients | |
| KR100309896B1 (en) | Agricultural/horticultural fungicidal composition) | |
| JPH05286970A (en) | 2-Acylamino-2-thiazoline compound, its production method and pest control agent | |
| JPH01117864A (en) | Substituted nicotinic acid derivative, its production and agricultural and horticultural fungicide containing said derivative as active component | |
| JP2639025B2 (en) | Substituted pyrazole carboxylic acid derivatives and agricultural and horticultural fungicides containing the same as active ingredients | |
| JPH064593B2 (en) | Pyrazolcarboxamide derivative and fungicide containing the same as an active ingredient | |
| CA1327583C (en) | Substituted carboxylic acid derivatives, processes for preparing the same and agricultural or horticultural fungicides containing the same | |
| KR910001439B1 (en) | Process for preparing 2-substituted phenyl-4,5,6,7matrix print head -tetrahydro-2h-isoindole-1,3-diones | |
| JPS61280471A (en) | Tetrahydrophthalimide derivative, production thereof and herbicide containing said derivative as active component | |
| JPH01211568A (en) | N-((3r)-1,1,3-trimethyl-4-indanyl)-2-methylnicotinic acid amide and production thereof | |
| JPH02142774A (en) | 2-(4-substituted phenyl)imidazolinones, their production methods, and herbicides containing them as active ingredients | |
| JP2623629B2 (en) | Pyrazole carbothioamide compounds and fungicides containing the same as active ingredients | |
| JPH01230569A (en) | Substituted carboxylic acid derivative, its production and agricultural and horticulatural fungicide containing said derivative as active component | |
| JPH064592B2 (en) | Pyrazolcarboxamide compound and fungicide containing the same as an active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19881105 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19930618 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19881105 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19970127 Patent event code: PE09021S01D |
|
| G160 | Decision to publish patent application | ||
| PG1601 | Publication of registration | ||
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19970925 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19971216 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19971216 End annual number: 3 Start annual number: 1 |
|
| PR1001 | Payment of annual fee |
Payment date: 20000701 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20011205 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20021205 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20031205 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20041210 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20051208 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20061211 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20071207 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20081202 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20091210 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20101208 Start annual number: 14 End annual number: 14 |
|
| FPAY | Annual fee payment |
Payment date: 20111118 Year of fee payment: 15 |
|
| PR1001 | Payment of annual fee |
Payment date: 20111118 Start annual number: 15 End annual number: 15 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |
Termination date: 20130409 Termination category: Expiration of duration |